| Title |
|
|
|
Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda
| |
| Author |
|
|
|
| |
| Abstract |
|
|
|
| SETTING: A human immunodeficiency virus (HIV) clinic in a setting of high tuberculosis (TB) and HIV prevalence. OBJECTIVE: To study the incidence of and factors associated with tuberculin skin test (TST) conversion in HIV patients on antiretroviral therapy (ART). DESIGN: Prospective cohort study of TST-negative, ART-naïve HIV patients (CD4 cell count < 250 cells/l) without active TB. TST was repeated at 2 months and, if negative, at 6 months. TST positivity was defined as an induration of ≥5 mm. Clinical examination, chest X-ray and CD4 cell counts were performed at baseline and follow-up. Proportions and incidence of TST conversion were calculated, and logistic regression analyses were performed. RESULTS: Of the 142 patients, 105 (75.5%) were females. The mean age was 35.9 years (standard deviation 8.1) and the median CD4 cell count was 119 cells/l (interquartile range 42168). The incidence of TST conversion was 30.2/100 person years (95%CI 19.546.8). Conversion was not associated with clinical, CD4 cell count or chest radiography findings. CONCLUSIONS: A high incidence of TST conversion was observed, supporting the World Health Organization recommendation to provide isoniazid preventive therapy (IPT) to all HIV patients in high TB prevalence settings. If case-control programmes choose to provide IPT only to TST-positive patients, repeat TST should be considered following initiation of ART. | | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
International journal of tuberculosis and lung disease. - Paris | |
| Publication |
|
|
|
Paris : 2013
| |
| ISSN |
|
|
|
1027-3719
| |
| Volume/pages |
|
|
|
17:3(2013), p. 336-341
| |
| ISI |
|
|
|
000315309100012
| |
| Full text (Publisher's DOI) |
|
|
| | |
|